Estrogen receptor α-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERβ1 and ERβ5: Potential molecular targets for chemoprevention

Clinical Cancer Research

Volumn 11, Issue 20, 2005, Pages 7579-7585

  Poola, Indira ^a   Fuqua, Suzanne A W ^b   De Witty, Robert L ^a   Abraham, Jessy ^a   Marshallack, Josephine J ^a   Liu, Aiyi ^c  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA1; ESTROGEN RECEPTOR BETA5; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ARTICLE; BREAST CANCER; CANCER PATIENT; CAUCASIAN; CHEMOPROPHYLAXIS; DRUG TARGETING; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACE DIFFERENCE; TRANSCRIPTION REGULATION;

AFRICAN AMERICANS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 27144517466     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0728     Document Type: Article

References (30)

1. Poola I, Abraham J, Baldwin K, Saunders A, Bhatnagar R. Estrogen receptor β4 and β5 are ligand independent transcription factors and negative modulators of ERα: cloning from human ovary and functional characterization. Endocrine 2005;27:227-38.
2. Green S, Walter P, Kumar A, et al. Human estrogen receptor: cDNA sequence, expression, and homology tov-erb-A. Nature 1986;320:134-9.
3. Ogawa S, Inoue S, Watanabe T, et al. The complete primary structure of human estrogen receptorβ (hERβ) and its heterodimerization with ERα in vivo and in vitro. Biochem Biophys Res Commun 1998;243:122-6.
4. Hopp TA, Weiss HL, Parra IS, et al. Low levels of estrogen receptor β protein predicts resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 2004;10:7490-9.
5. Poola I, Abraham J, Liu A. Alternatively spliced ERβ mRNAs are differentially altered during breast carcinogenesis. J Steroid Biochem Mol Biol 2002;82:169-79.
6. Poola I, Abraham J, Baldwin K. Identification of ten alternatively spliced ERβ mRNAs in human ovary, breast, bone and uterus tissues: alternative splicing of ERβ mRNA is distinct from that of ERα. FEBS Lett 2002;516:133-8.
7. Poola I, Williams DM, Koduri S, et al. Quantitation of estrogen receptor mRNA copy numbers in breast cancer cell lines and tumors. Anal Biochem 1998;258:209-15.
8. Poola I, Koduri S, Chatra S, Clarke R. Identification of twenty alternatively spliced estrogen receptor α mRNAs in breast cancer cell lines and tumors using splice targeted primer approach. J Steroid Biochem Mol Biol 2002;72:249-58.
9. Poola I. Molecular assay to generate expression profile of eight ERα isoform mRNA copy numbers in picogram amounts of total RNA from breast cancer tissues. Anal Biochem 2003;314:217-26.
10. Poola I. Molecular assays to profile 10 estrogen receptor α isoform mRNA copy numbers in ovary, breast, uterus and bone tissues. Endocrine 2003;22:101-11.
11. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-81.
12. Poola I. An estrogen inducible 104 kDa chaperone glycoprotein binds ferric iron containing proteins: a possible role in intracellular iron trafficking. FEBS Lett 1997;416:139-42.
13. Poola I, Kiang J. The estrogen inducible transferrin receptor like membrane glycoprotein is related to stress regulated proteins. J Biol Chem 1994;268:21762-9.
14. Laemmil UK. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 1970;227:680-5.
15. Towbin H, Staehlin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4.
16. Hall JM, McDonnell DP. The estrogen receptor β isoform of the human estrogen receptor modulates estrogen receptor α transcriptional activity and is a key regulator of the cellular responses to estrogens and anti-estrogens. Endocrinology 1999;140:5566-78.
17. Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001;276:36869-72.
18. Wehua Z, Saji S, Makinen S, et al. Estrogen receptor (ER) β, a modulator of ERα in uterus. Proc Natl Acad Sci U S A 20001;97:5936-41.
19. Dotzlaw H, Leygue E, Watson P, Murphy L. Expression of estrogen receptor β in human breast tumors. J Clin Endocrinol Metab 1997;82:2371-4.
20. Fuqua SAW, Schiff R, Parra I, et al. Expression of wild type and variant estrogen receptor et al. isoform proteins in human breast cancer. Cancer Res 1999;59:5425-8.
21. Fuqua SAW, Schiff R, Parra I, et al. Estrogen receptor β protein in breast cancer: correlation with clinical tumor parameters. Cancer Res 2003;63:2434-9.
22. Speirs V, Parks AT, Kerin MJ, et al. Co-expression of estrogen receptor α and β: poor prognostic factors in human breast cancer? Cancer Res 1999;59:525-8.
23. Skliris GP, Carder PJ, Lansdown MRJ, Speirs V. Immunohistochemical detectionof ERβ in breast cancer: towards more detailed receptor profiling? Br J Cancer 2001;84:1095-8.
24. Poola I, Clarke R, DeWitty RL, Leffall LD. Functionally active estrogen receptor isoform profiles in the breast tumors of African American women are different from the profiles in breast tumors of Caucasian women. Cancer 2002;94:615-23.
25. Speirs V, Carder CJ, Lane S, et al. Oestrogen receptor β: what it means for patients with breast cancer. Lancet Oncol 2004;5:174-81.
26. Jenson EV, Cheng G, Palmieri C, et al. Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci U S A 2001;98:15197-202.
27. Shaw JA, Udplamd K, Mosquera J-M, et al. Oestrogen receptors α and β differ in normal human breast and breast carcinomas. J Pathol 2002;198:450-7.
28. Chu KC, Lamar CA, Freeman HP. Racial disparities in breast carcinoma survival rates. Cancer 2003;97:2853-60.
29. Beverly LN, Flanders D, Go RCP, Soong SI. A comparison of estrogen and progesterone receptors in Black and White breast cancer patients. Am J Public Health 1987;77:351-3.
30. Moormeier J. Breast cancer in Black women. Ann Intern Med 1996;15:897-905.